Vivos Therapeutics Schedules First Quarter 2022 Financial Results Conference Call
28. April 2022 07:30 ET
|
Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., April 28, 2022 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a medical technology company focused on developing and commercializing...
Vivos Therapeutics Opens Third U.S. Multidisciplinary Center to Treat Patients Suffering from Sleep Apnea with The Vivos Method
26. April 2022 08:26 ET
|
Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., April 26, 2022 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (NASDAQ: VVOS) (“Vivos'' or the “Company''), a medical technology company focused on developing and...
Vivos Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Update
31. März 2022 16:05 ET
|
Vivos Therapeutics, Inc
Fourth Quarter Revenue Increased 33% Year-Over-Year While Full Year Revenue Increased 29% Management to Host Conference Call Today at 5:00 pm ET HIGHLANDS RANCH, Colo., March 31, 2022 (GLOBE...
Vivos Therapeutics Schedules Fourth Quarter and Full Year 2021 Financial Results Conference Call
31. März 2022 08:14 ET
|
Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., March 31, 2022 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a medical technology company focused on developing and commercializing...
Fast Company Selects Vivos Therapeutics for 2022 “World’s Most Innovative Companies” List
08. März 2022 09:11 ET
|
Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., March 08, 2022 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or “the Company'') (NASDAQ: VVOS), a medical technology company focused on developing and commercializing...
Vivos Therapeutics Rebrands Proprietary Clinical Protocol for Treating Patients with Breathing and Sleep Disorders
03. März 2022 08:00 ET
|
Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., March 03, 2022 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a medical technology company focused on developing and commercializing...
Vivos Therapeutics to Participate in Upcoming Investor Conferences
02. März 2022 08:00 ET
|
Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., March 02, 2022 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a medical technology company focused on developing and commercializing...
Vivos Therapeutics to Present at March 2022 World Sleep Congress in Rome
24. Februar 2022 08:00 ET
|
Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or “the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing...
Vivos Therapeutics Files for US Patent on Proprietary New Clinical Protocols After Seeing Further Significant Improvement in Reduction of Key Sleep Apnea Metric
27. Januar 2022 07:30 ET
|
Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., Jan. 27, 2022 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or “the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing...
Vivos Therapeutics Announces 18X Increase in Sleep Apnea Diagnostic Testing By Vivos Dentists Using SleepImage Technology
19. Januar 2022 07:30 ET
|
Vivos Therapeutics, Inc
Vivos Also Announces Improved Pricing Agreement With SleepImage Dentists and Patients Report Exceptional User Experience with SleepImage Home Sleep Test HIGHLANDS RANCH, Colo., Jan. 19, 2022 ...